| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |